Awareness, accessibility and limited resources are some of the barriers the healthcare industry faces when it comes to getting vision care to underserved communities. Technology can alleviate this. In a new episode of Slice of Healthcare, our CEO, Vasiliki (Vicky) Demas, discusses how identifeye HEALTH is making vision care more accessible through innovative AI technology. From her early career, through her past experiences, including at Google Life Sciences and at GRAIL, Vicky’s journey has led her to our mission to democratize retinal imaging and improving patient outcomes. Listen in on her conversation with Jared S. Taylor here: https://lnkd.in/gyryZNEv #HealthcareInnovation #DiabetesCare #EyeHealth
identifeye HEALTH
Medical Equipment Manufacturing
Guilford, CT 3,772 followers
We’re using innovative ML techniques to democratize access to the abundance of health insights available in the eye
About us
The eye is the window into the body. Identifeye Health is creating a non-invasive test that detects health conditions through the eyes. Identifeye Health is part of the 4Catalyzer accelerator, with over $700 Million in funding, 300 scientists and engineers. Our offices are in Guilford CT, New York City, and Palo Alto. 4Catalyzer is founded by Jonathan Rothberg, the inventor of “Next-Gen” DNA sequencing and ultrasound-on-a-chip (Butterfly Network).
- Website
-
https://www.identifeye.health/
External link for identifeye HEALTH
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Guilford, CT
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
530 Old Whitfield Rd
Guilford, CT 06437, US
-
735 Shasta Street
Redwood City, CA 94063, US
Employees at identifeye HEALTH
-
Maya Venkatraman
-
Jonathan Rothberg
#ThanksObama - email joinus@4Catalyzer.com to help save the life of someone you love. Follow me on Twitter @JMRothberg
-
Jose Castañon
Commercial Strategy | Product Marketing | Market Development | Digital Health | Medical Device
-
David Rosenthal M.D.
Healthcare advisor, investor, and entrepreneur. Physician & Faculty @Yale | Venture Partner @ Alleycorp | Former Chief Medical Officer @Tesseract…
Updates
-
Our CEO, Vasiliki (Vicky) Demas, is attending this year’s Forbes Power Women’s Summit! For more than a decade, this summit has brought women together to discuss the most critical issues leaders are facing today and the playbook for navigating challenges and opportunities moving forward. Interested in connecting with Vicky while she’s there? Feel free to drop us a line. https://lnkd.in/eAK_6Vie #ForbesWomen #PowerWomenSummit
2024 Forbes Power Women's Summit - Forbes Connect
social-www.forbes.com
-
A new study from the University of Houston College of Optometry aims to understand who might be at risk for future vision loss. The study will analyze the vision health of patients with prediabetes and diabetes. By investigating both the front and back of the eye, as well as different types of glucose dysfunction, this research could lead to better preventative strategies and, ultimately, help preserve vision. https://lnkd.in/exCPvPVR #DiabeticRetinopathy #EyeHealth #EarlyDetection
-
The early stages of diabetic retinopathy often go unnoticed until it’s too late. That’s where AI and automation can make a difference. Our CEO, Vasiliki (Vicky) Demas, recently joined Dr. Bob Kaiser on the Business of AI in Healthcare podcast to discuss how identifeye HEALTH is using AI to make diabetic retinopathy screening more accessible to detect disease early and prevent severe complications and vision loss. Tune in to the full conversation to learn more about our approach to addressing one of the leading causes of blindness: https://lnkd.in/eYmySRej #HealthcareAI #DiabeticRetinopathy #VisionHealth
Transforming Retinal Care: AI image assessment and diagnosis
podcasts.apple.com
-
Research coming out of this year’s ASRS – American Society of Retina Specialists annual meeting shows promise for better diabetic retinopathy management, A recent article from Medscape analyzes the research, including new findings on risk factors and potential supplementary treatments. One doctor noted that new strategies for treating diabetic retinopathy address the underlying causes of the disease rather than focusing solely on vascular endothelial growth factor (VEGF). This could lead to more effective and long-lasting drugs. Read about the emerging therapies that could significantly shape future treatment plans for this eye disease. https://lnkd.in/di47Jn27
Research Promises Better Diabetic Retinopathy Management
medscape.com
-
A recent study in Nature Portfolio shared an AI-powered approach to diagnosing diabetic retinopathy. According to the study, researchers developed and validated deep learning systems that could predict when diabetic retinopathy would reach a vision-threatening stage up to three years in advance. The findings show early promise in leveraging AI to enable closer monitoring and earlier intervention for people at higher risk of the disease. Details of the findings can be found here: https://lnkd.in/eD-Pb8uy #EarlyDetection #DiabeticRetinopathy #AI
Predicting 1, 2 and 3 year emergent referable diabetic retinopathy and maculopathy using deep learning - Communications Medicine
nature.com
-
A unique collaboration at UC San Diego showcased AI's potential in vision health. The partnership aimed to develop AI tools for faster, more accurate diagnosis, drug prediction, and therapy development for retinal diseases. Electrical engineering graduate students partnered with ophthalmologists for five years, publishing 21 papers highlighting advances in clinical and engineering journals. While the tools have shown promise, the researchers say AI is ultimately meant to enhance ophthalmologists' decision-making. Read about it here: https://lnkd.in/g8Z9P4S6 #Visionhealth #Ophthalmology #AI
Using AI to Enable Better Vision – for Both Humans and Machines
today.ucsd.edu
-
Advancements in understanding the root causes of vision loss are on the horizon. A study by Wayne State University researchers has uncovered new clues about retinal neovascularization, a leading cause of vision loss in various groups, including people with diabetes. Their findings suggest a potential new approach to treating conditions like premature retinopathy and diabetic retinopathy. By targeting a specific protein, researchers believe they can prevent the growth of abnormal blood vessels in the retina, preserving vision. Read about the findings here: https://lnkd.in/eAqGkd77 #visionloss #diabeticretinopathy #visionresearch
Detroit researchers find new clues in causes of vision loss in various ocular diseases that may lead to new treatments
research.wayne.edu
-
Primary care settings can be a game-changer for diabetic retinopathy screenings. According to a new study in Ophthalmology Times, researchers used digital fundus photography and automated analysis to significantly increase screening rates among underserved populations. This included an increase in interpretable exams and detection rates as well as a reduction in insufficient exam rates. This is a significant step forward in democratizing access to better eye care. At identifeye HEALTH, we're committed to developing innovative solutions that bring high-quality eye care to everyone, everywhere. https://lnkd.in/ghWJyv5A #EyeonDiabetes #EyecCare #DiabeticRetinopathy
Researchers target screening rates for diabetic retinopathy among low-income minority patients
ophthalmologytimes.com
-
A recent study in Nature Portfolio has shed light on the complex mechanisms behind diabetic retinopathy. Thanks to AI, researchers have identified key factors contributing to eye disease development. Findings like this could pave the way for more effective prevention and treatment strategies. Read the full study here: https://lnkd.in/eSrRD2dh #AI #DiabeticRetinopathy #Visionhealth
Identification of key biomarkers for early warning of diabetic retinopathy using BP neural network algorithm and hierarchical clustering analysis - Scientific Reports
nature.com